Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography

Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy

(2013) Aine M. Kelly et al.   ANNALS OF INTERNAL MEDICINE

Evidence-based management of patients undergoing PCI: Contrast-induced acute kidney injury

(2010) Adriano Caixeta et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

(2010) et al.   EUROPEAN HEART JOURNAL

Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced Nephropathy

(2010) Samuel N. Heyman et al.   INVESTIGATIVE RADIOLOGY

Impact of High-Dose N-Acetylcysteine Versus Placebo on Contrast-Induced Nephropathy and Myocardial Reperfusion Injury in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2010) Holger Thiele et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High-dose N-acetylcysteine for the Prevention of Contrast-induced Nephropathy

(2009) Hariprasad Trivedi et al.   AMERICAN JOURNAL OF MEDICINE

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

(2009)   Trials